Compass Pathways Plc ADR (CMPS) Stock Price, Quote & News

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities

Sector: Healthcare

Website: compasspathways.com

Address:

33 Broadwick Street, London, United Kingdom

McGuireTO Aug. 6 at 8:54 PM

$CMPS weak bounce - is another leg down coming? CMPS weak bounce from the daily EMA12 could be setting up an hourly bear flag for another leg down. The hourly SMA50 and Daily SMA200 are important levels so I would look to those levels for support and hourly oversold RSI if today's low doesn't hold. Short term resistance on Thursday will be today's high. I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates! https://www.tradingview.com/chart/CMPS/fW0Ns5on-CMPS-weak-bounce-is-another-leg-down-coming/

0 · Reply

UncleJudd Aug. 6 at 7:41 PM

$CMPS In Politico today https://www.politico.com/newsletters/future-pulse/2025/08/06/psychedelic-medicine-ceo-eyes-chances-under-maha-00494736

0 · Reply

brodobagginz Aug. 6 at 6:28 PM

$ATAI $CMPS wondering why these two are inching closer to parity - seems a little buy-out ish to me...

2 · Reply

cacci11 Aug. 6 at 2:15 PM

$CMPS the whole sector is suffering from bored, broke ass day skaters. Hold the line

0 · Reply

Deejay601 Aug. 6 at 12:20 PM

$CMPS brace yourself the day traders are coming lol good luck everyone

0 · Reply

McGuireTO Aug. 6 at 12:26 AM

$CMPS healthy sideways consolidation Daily timeframe is just fine but I'm watching closely for clues as the weekly chart may be getting a little toppy just below our key resistances around 5.22. In the short tern, nothing changes as long as we are trading in Monday's range, we need to see a break of the high or the low of that candle in order to give us clues on direction and whether or not we can avoid further weekly consolidation and see the bounce continue. I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates! https://www.tradingview.com/chart/CMPS/F0T7Q2hM-CMPS-healthy-sideways-consolidation/

0 · Reply

McGuireTO Aug. 5 at 2:33 PM

$MDMA.CSE $MDXXF Pharmala Biotech has set a new support level and is slowly creeping back to resistance with big bid support and orders chipping away at the key level. I'm anticipating this to get a sympathy run along with $ATAI $MNMD and $CMPS and the chart is tight enough that this can be an explosive move

1 · Reply

twiggs462 Aug. 5 at 1:26 PM

$CMPS $ATAI $MNMD

0 · Reply

macrossluvsrobotech Aug. 5 at 1:15 PM

$CMPS $ATAI $MNMD "New study links psychedelic use to mental health recovery in times of crisis" https://www.psypost.org/new-study-links-psychedelic-use-to-mental-health-recovery-in-times-of-crisis/

0 · Reply

jattboy Aug. 5 at 6:23 AM

$CMPS this is day trade scalping play for now

1 · Reply

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Jul 31, 2025, 10:32 AM EDT - 6 days ago

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 6:30 AM EDT - 6 days ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 8 days ago

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 22, 2025, 6:30 AM EDT - 15 days ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 10, 2025, 4:00 PM EDT - 27 days ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jun 24, 2025, 2:47 PM EDT - 6 weeks ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 23, 2025, 8:25 AM EDT - 6 weeks ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Jun 23, 2025, 8:12 AM EDT - 6 weeks ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 6:48 AM EDT - 6 weeks ago

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:30 AM EDT - 6 weeks ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

May 14, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 11:14 AM EDT - 3 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Apr 29, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 28, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 22, 2025, 6:00 AM EDT - 3 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 28, 2025, 5:01 PM EDT - 4 months ago

This Is a Test From GlobeNewswire

ALVO

Mar 26, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 11, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Feb 28, 2025, 5:08 PM EST - 5 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 27, 2025, 4:02 PM EST - 5 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 10:41 AM EST - 5 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:30 AM EST - 5 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 25, 2025, 4:00 PM EST - 5 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 6:30 AM EST - 6 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 5, 2025, 6:30 AM EST - 6 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 21, 2025, 6:30 AM EST - 7 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 10, 2025, 7:01 AM EST - 7 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Dec 18, 2024, 6:30 AM EST - 8 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Nov 25, 2024, 4:00 PM EST - 9 months ago

Compass Pathways to Participate in December Investor Conferences

Nov 14, 2024, 7:44 AM EST - 9 months ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 5, 2024, 6:58 AM EST - 9 months ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Nov 1, 2024, 5:10 PM EDT - 9 months ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Oct 31, 2024, 2:49 PM EDT - 9 months ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:30 AM EDT - 9 months ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 24, 2024, 6:30 AM EDT - 10 months ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Sep 23, 2024, 7:00 AM EDT - 11 months ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Aug 28, 2024, 6:00 AM EDT - 1 year ago

Compass Pathways to participate in three investor conferences in September

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

Aug 4, 2024, 1:22 AM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jun 26, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Jun 24, 2024, 4:01 PM EDT - 1 year ago

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

MNMD

May 11, 2024, 5:31 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

McGuireTO Aug. 6 at 8:54 PM

0 · Reply

UncleJudd Aug. 6 at 7:41 PM

$CMPS In Politico today https://www.politico.com/newsletters/future-pulse/2025/08/06/psychedelic-medicine-ceo-eyes-chances-under-maha-00494736

0 · Reply

brodobagginz Aug. 6 at 6:28 PM

$ATAI $CMPS wondering why these two are inching closer to parity - seems a little buy-out ish to me...

2 · Reply

cacci11 Aug. 6 at 2:15 PM

$CMPS the whole sector is suffering from bored, broke ass day skaters. Hold the line

0 · Reply

Deejay601 Aug. 6 at 12:20 PM

$CMPS brace yourself the day traders are coming lol good luck everyone

0 · Reply

McGuireTO Aug. 6 at 12:26 AM

0 · Reply

McGuireTO Aug. 5 at 2:33 PM

1 · Reply

twiggs462 Aug. 5 at 1:26 PM

$CMPS $ATAI $MNMD

0 · Reply

macrossluvsrobotech Aug. 5 at 1:15 PM

$CMPS $ATAI $MNMD "New study links psychedelic use to mental health recovery in times of crisis" https://www.psypost.org/new-study-links-psychedelic-use-to-mental-health-recovery-in-times-of-crisis/

0 · Reply

jattboy Aug. 5 at 6:23 AM

$CMPS this is day trade scalping play for now

1 · Reply

Gaelic73 Aug. 4 at 8:26 PM

$CMPS There seems to be resistance at around $4.80. If we can get by that, we hopefully should blow past $5.

0 · Reply

ThatDudeWithNoMoney Aug. 4 at 5:30 PM

$IVF it’s coo, let them run their fear tactics. It’s working on some of the people but if you bought early you’re not clouded by the fog of war. You see the light. Plays I scalped today: 👇👇👇👇👇👇 $OPEN $CMPS Lost money on $FIG today but that’s how it goes!! *This is strictly speculative insight and not financial advice*

2 · Reply

BobJohnBuoy666 Aug. 4 at 5:19 PM

$CMPS selling 10 strike calls here

1 · Reply

SlayQueenOfCalls Aug. 4 at 5:12 PM

$CMPS “lowers price target to $40” Who will host the yacht party?

0 · Reply

FBP Aug. 4 at 4:54 PM

$CMPS ride the wave

1 · Reply

cjtrades01 Aug. 4 at 4:35 PM

🍄🍄🍄 $MNMD $CYBN $CMPS

0 · Reply

SlayQueenOfCalls Aug. 4 at 3:37 PM

$CMPS ok I got the position but now I want to be part of the trials 😀😀

1 · Reply

SlayQueenOfCalls Aug. 4 at 3:36 PM

$CMPS sure is!!

0 · Reply

bmills25 Aug. 4 at 2:25 PM

$CMPS This is going higher

0 · Reply

UncleJudd Aug. 3 at 7:30 PM

$CMPS New article about the future of CMPS https://www.ainvest.com/news/compass-pathways-overly-confident-management-overly-skeptical-market-2508-66/

0 · Reply

Tradetime3472 Aug. 3 at 2:43 PM

$PBM our trial design is identical to $CMPS phase2 trial. difference is we are using a natural psilocybin which is more effective than synthetic. They have a $400M MC. We have a $2M MC with probably around $4M in cash at this moment. https://www.kcl.ac.uk/news/largest-trial-to-date-shows-that-psilocybin-reduces-depression-symptoms

1 · Reply

McGuireTO Aug. 2 at 9:28 PM

Cathy Woods bought 23k more $CMPS on Friday Aug 1.

0 · Reply

Market Cap	429.82M
Revenue (ttm)	0.00
Net Income (ttm)	-155.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.19

Volume	719,000
Avg Vol	3,236,302
Day's Range	N/A - N/A
Shares Out	95.94M
Stochastic %K	64%
Beta	2.17
Analysts	Strong Sell
Price Target	$15.44